Nolato AB (publ) (NOLA-B) - Total Assets

Latest as of March 2026: Skr9.75 Billion SEK ≈ $1.05 Billion USD

Based on the latest financial reports, Nolato AB (publ) (NOLA-B) holds total assets worth Skr9.75 Billion SEK (≈ $1.05 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Nolato AB (publ) - Total Assets Trend (2002–2025)

This chart illustrates how Nolato AB (publ)'s total assets have evolved over time, based on quarterly financial data. Also see Nolato AB (publ) (NOLA-B) market capitalisation for the company's overall valuation and market capitalisation.

Nolato AB (publ) - Asset Composition Analysis

Current Asset Composition (December 2025)

Nolato AB (publ)'s total assets of Skr9.75 Billion consist of 40.1% current assets and 59.9% non-current assets. Review NOLA-B total debt and obligations to assess the company's total debt and financial obligations.

Asset Category Amount (SEK) % of Total Assets
Cash & Equivalents Skr482.00 Million 5.2%
Accounts Receivable Skr1.60 Billion 17.2%
Inventory Skr1.09 Billion 11.7%
Property, Plant & Equipment Skr3.36 Billion 36.2%
Intangible Assets Skr162.00 Million 1.8%
Goodwill Skr2.01 Billion 21.7%

Asset Composition Trend (2002–2025)

This chart illustrates how Nolato AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See NOLA-B live share price for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Nolato AB (publ)'s current assets represent 40.1% of total assets in 2025, a decrease from 50.8% in 2002.
  • Cash Position: Cash and equivalents constituted 5.2% of total assets in 2025, down from 9.3% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, an increase from 4.0% in 2002.
  • Asset Diversification: The largest asset category is property, plant & equipment at 36.2% of total assets.

Nolato AB (publ) Competitors by Total Assets

Key competitors of Nolato AB (publ) based on total assets are shown below.

Company Country Total Assets
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
Germany €2.83 Billion
TransMedics Group Inc
NASDAQ:TMDX
USA $1.46 Billion
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
China CN¥16.89 Billion
Novocure Ltd
NASDAQ:NVCR
USA $787.93 Million
Shenzhen New Industries Biomedical
SHE:300832
China CN¥9.58 Billion
Jafron Biomedical Co Ltd
SHE:300529
China CN¥5.20 Billion
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581
China CN¥2.70 Billion
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
China CN¥1.79 Billion

Nolato AB (publ) - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.68 2.04 1.30
Quick Ratio 1.21 1.45 0.96
Cash Ratio 0.00 0.31 0.40
Working Capital Skr1.62 Billion Skr1.93 Billion Skr919.00 Million

Nolato AB (publ) - Advanced Valuation Insights

This section examines the relationship between Nolato AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.25
Latest Market Cap to Assets Ratio 0.15
Asset Growth Rate (YoY) -4.2%
Total Assets Skr9.28 Billion
Market Capitalization $1.37 Billion USD

Valuation Analysis

Below Book Valuation: The market values Nolato AB (publ)'s assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Nolato AB (publ)'s assets decreased by 4.2% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Nolato AB (publ) (2002–2025)

The table below shows the annual total assets of Nolato AB (publ) from 2002 to 2025.

Year Total Assets Change
2025-12-31 Skr9.28 Billion
≈ $998.89 Million
-4.19%
2024-12-31 Skr9.69 Billion
≈ $1.04 Billion
+4.17%
2023-12-31 Skr9.30 Billion
≈ $1.00 Billion
-7.07%
2022-12-31 Skr10.01 Billion
≈ $1.08 Billion
-0.48%
2021-12-31 Skr10.05 Billion
≈ $1.08 Billion
+15.79%
2020-12-31 Skr8.68 Billion
≈ $934.54 Million
+41.57%
2019-12-31 Skr6.13 Billion
≈ $660.12 Million
+18.97%
2018-12-31 Skr5.16 Billion
≈ $554.87 Million
+8.50%
2017-12-31 Skr4.75 Billion
≈ $511.39 Million
+21.10%
2016-12-31 Skr3.92 Billion
≈ $422.29 Million
+21.37%
2015-12-31 Skr3.23 Billion
≈ $347.92 Million
+10.95%
2014-12-31 Skr2.91 Billion
≈ $313.59 Million
+13.25%
2013-12-31 Skr2.57 Billion
≈ $276.90 Million
-2.32%
2012-12-31 Skr2.63 Billion
≈ $283.46 Million
+22.85%
2011-12-31 Skr2.14 Billion
≈ $230.73 Million
-8.77%
2010-12-31 Skr2.35 Billion
≈ $252.90 Million
+11.22%
2009-12-31 Skr2.11 Billion
≈ $227.39 Million
-0.61%
2008-12-31 Skr2.13 Billion
≈ $228.79 Million
+10.84%
2007-12-31 Skr1.92 Billion
≈ $206.41 Million
+11.25%
2006-12-31 Skr1.72 Billion
≈ $185.53 Million
+3.36%
2005-12-31 Skr1.67 Billion
≈ $179.50 Million
+4.38%
2004-12-31 Skr1.60 Billion
≈ $171.97 Million
-12.92%
2003-12-31 Skr1.83 Billion
≈ $197.48 Million
-3.17%
2002-12-31 Skr1.90 Billion
≈ $203.93 Million
--

About Nolato AB (publ)

ST:NOLA-B Sweden Medical Devices
Market Cap
$1.37 Billion
Skr12.69 Billion SEK
Market Cap Rank
#7581 Global
#115 in Sweden
Share Price
Skr52.50
Change (1 day)
+0.00%
52-Week Range
Skr46.25 - Skr63.75
All Time High
Skr109.65
About

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and… Read more